✦ LIBER ✦

Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma

✍ Scribed by Philip H. Konits; Merrill J. Egorin; David A. Echo; Joseph Aisner; Paul A. Andrews; Matthew E. May; Nicholas R. Bachur; Peter H. Wiernik

Publisher: Springer
Year: 1982
Tongue: English
Weight: 488 KB
Volume: 8
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00255484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of intravenous 6-thioguan

Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas

✍ Jaffer A. Ajani; Richard Pazdur; Rodger J. Winn; James L. Abbruzzese; Bernard Le 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 213 KB

In a phase II study, 32 patients with advanced pancreatic carcinoma were treated with intravenous 6-thioguanine. A 30-min infusion of 55 mg/m ~ (starting dose) was administered once a day for 5 consecutive days, the course being repeated every 5 weeks. A median of two courses (range, 1-10) was admin

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patients with colorectal carcinoma

✍ Neal J. Meropol; Nicholas J. Petrelli; Youcef M. Rustum; Miguel Rodriguez-Bigas; 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 529 KB

Phase II trial of 5 day continuous intra

Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Flavio Kruter; Mario Eisenberger; Victoria Sinibaldi; Christine Engstrom; Maria 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 221 KB

A Phase II trial of high dose epirubicin

A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma

✍ Kathy D. Miller; Nikhil Munshi; David Loesch; Lawrence H. Einhorn; George W. Sle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## BACKGROUND. Anthracyclines are among the most active drugs in the treatment of breast carcinoma and exhibit a steep dose-response curve in vitro. This trial was performed to determine the efficacy and toxicity of epirubicin in the treatment of patients with advanced breast carcinoma when adminis

Bowel rest, intravenous hydration, and c

Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma

✍ Nicholas J. Petrelli; Miguel Rodriguez-Bigas; Youcef Rustum; Lemuel Herrera; Pat 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 2 views

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer